These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2496666)

  • 21. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
    Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
    Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
    Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
    Suzuki K; Itaya S; Tsuge I; Matsuda T; Motai H; Kobayashi T; Shimada J; Baba S
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1349-54. PubMed ID: 8346933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
    Inoue S; Shibata S; Okumura A; Tanaka T; Onitsuka Y; Yoshimura T; Aiko A; Ikuta Y; Fukuma K; Matsuura K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):499-504. PubMed ID: 3923940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
    Kato T; Yakushiji M; Yamabe T; Sugimori H; Hidaki T; Tsukamoto N; Tazaki T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1221-7. PubMed ID: 8031165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
    Hatae M; Terahara M; Hokanishi H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2386-92. PubMed ID: 6437345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
    Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of combination chemotherapy with topical application of 5-FU ointment to mice's tongue and UFT].
    Tateishi A; Sakaki Y; Kameyama Y; Hara I; Yamada N
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1877-85. PubMed ID: 2118335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
    Suzuki M; Sekiguchi I; Tamada T; Nishida M
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
    Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
    Suemasu K; Nomoto C; Higashi Y
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor effect of UFT against differentiated thyroid cancer].
    Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of OK-432 on UFT activation].
    Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
    Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.